Skip to content
Home
Audrey L. Schroeder, M.S.

Audrey L. Schroeder, M.S.

she/her

Contact

Call Center (585) 276-3000

Connect with Audrey L. Schroeder, M.S.

Master of Science in Genetic Counseling Program

About Me

Audrey Schroeder serves as the Program Director of the Master of Science in Genetic Counseling (MSGC) program within the School of Medicine and Dentistry. Prior to her role as Program Director, Ms. Schroeder was a practicing genetic counselor for 16 years. She has been with the University of Rochest...
Audrey Schroeder serves as the Program Director of the Master of Science in Genetic Counseling (MSGC) program within the School of Medicine and Dentistry. Prior to her role as Program Director, Ms. Schroeder was a practicing genetic counselor for 16 years. She has been with the University of Rochester Medical Center since 2013, and was previously a genetic counselor with Roswell Park Cancer Institute (Buffalo, NY), New York Methodist Hospital (NYC), and Metropolitan Hospital Center (NYC). Primary clinical interests have included Pediatric Genetics, Adult General Genetics, Cancer Genetics, and Cardiogenetics. In addition to providing clinical patient care, she has worked with a number of medical trainees and genetic counseling students. She is passionate about expanding genetic counseling educational training and genetic services in the Upstate New York region, and led the development of the MSGC program within the School of Medicine and Dentistry.

Professional Memberships

American Board of Genetic Counseling
Genetic Counselor Educators Association (previously Association of Genetic Counseling Program Directors)
National Society of Genetic Counselors
New York State Genetics Task Force

Faculty Appointments

Senior Associate - Department of Pediatrics, Genetics (SMD)

Credentials

Education

MS | Icahn School of Medicine at Mount Sinai. Genetic Counseling. 2006

BS | University of Maryland. Cell Biology and Molecular Genetics. 2000

Publications

Journal Articles

Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites.

de Prisco N, Ford C, Elrod ND, Lee W, Tang LC, Huang KL, Lin A, Ji P, Jonnakuti VS, Boyle L, Cabaj M, Botta S, Õunap K, Reinson K, Wojcik MH, Rosenfeld JA, Bi W, Tveten K, Prescott T, Gerstner T, Schroeder A, Fong CT, George-Abraham JK, Buchanan CA, Hanson-Khan A, Bernstein JA, Nella AA, Chung WK, Brandt V, Jovanovic M, Targoff KL, Yalamanchili HK, Wagner EJ, Gennarino VA

Science advances.. 2023 February 179 (7):eade4814. Epub 02/17/2023.

Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.

Salsench EM, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M, Al-Sannaa NA, Girgis MY, Silveira TRD, Bauer P, Schroeder A, Fong CT, Begtrup A, Babaei M, Toosi MB, Ashrafzadeh F, Imannezhad S, Doosti M, Ahangari N, Torbati PN, Karimiani EG, Murphy D, Cali E, Kaya IH, AlMuhaizea M, Colak D, Cardona-Londoño KJ, Arold ST, Houlden H, Bertoli-Avella A, Kaya N, Barakat TS

Brain : a journal of neurology.. 2021 November 29144 (10):e85. Epub 1900 01 01.

Allelic and dosage effects of NHS in X-linked cataract and Nance-Horan syndrome: a family study and literature review.

Miller C, Gertsen BG, Schroeder AL, Fong CT, Iqbal MA, Zhang B

Molecular cytogenetics.. 2021 October 714 (1):48. Epub 10/07/2021.

Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome.

Sheppard SE, Campbell IM, Harr MH, Gold N, Li D, Bjornsson HT, Cohen JS, Fahrner JA, Fatemi A, Harris JR, Nowak C, Stevens CA, Grand K, Au M, Graham JM, Sanchez-Lara PA, Campo MD, Jones MC, Abdul-Rahman O, Alkuraya FS, Bassetti JA, Bergstrom K, Bhoj E, Dugan S, Kaplan JD, Derar N, Gripp KW, Hauser N, Innes AM, Keena B, Kodra N, Miller R, Nelson B, Nowaczyk MJ, Rahbeeni Z, Ben-Shachar S, Shieh JT, Slavotinek A, Sobering AK, Abbott MA, Allain DC, Amlie-Wolf L, Au PYB, Bedoukian E, Beek G, Barry J, Berg J, Bernstein JA, Cytrynbaum C, Chung BH, Donoghue S, Dorrani N, Eaton A, Flores-Daboub JA, Dubbs H, Felix CA, Fong CT, Fung JLF, Gangaram B, Goldstein A, Greenberg R, Ha TK, Hersh J, Izumi K, Kallish S, Kravets E, Kwok PY, Jobling RK, Knight Johnson AE, Kushner J, Lee BH, Levin B, Lindstrom K, Manickam K, Mardach R, McCormick E, McLeod DR, Mentch FD, Minks K, Muraresku C, Nelson SF, Porazzi P, Pichurin PN, Powell-Hamilton NN, Powis Z, Ritter A, Rogers C, Rohena L, Ronspies C, Schroeder A, Stark Z, Starr L, Stoler J, Suwannarat P, Velinov M, Weksberg R, Wilnai Y, Zadeh N, Zand DJ, Falk MJ, Hakonarson H, Zackai EH, Quintero-Rivera F

American journal of medical genetics. Part A.. 2021 June 185 (6):1649-1665. Epub 03/30/2021.

A Germline Variant in the PANX1 Gene Has Reduced Channel Function and Is Associated with Multisystem Dysfunction.

Shao Q, Lindstrom K, Shi R, Kelly J, Schroeder A, Juusola J, Levine KL, Esseltine JL, Penuela S, Jackson MF, Laird DW

The Journal of biological chemistry.. 2016 June 10291 (24):12432-12443. Epub 04/15/2016.

De Novo Mutations of RERE Cause a Genetic Syndrome with Features that Overlap Those Associated with Proximal 1p36 Deletions.

Fregeau B, Kim BJ, Hernández-García A, Jordan VK, Cho MT, Schnur RE, Monaghan KG, Juusola J, Rosenfeld JA, Bhoj E, Zackai EH, Sacharow S, Barañano K, Bosch DG, de Vries BB, Lindstrom K, Schroeder A, James P, Kulch P, Lalani SR, van Haelst MM, van Gassen KL, van Binsbergen E, Barkovich AJ, Scott DA, Sherr EH

American journal of human genetics.. 2016 May 598 (5):963-970. Epub 04/14/2016.

WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.

DeSanto C, D'Aco K, Araujo GC, Shannon N, Vernon H, Rahrig A, Monaghan KG, Niu Z, Vitazka P, Dodd J, Tang S, Manwaring L, Martir-Negron A, Schnur RE, Juusola J, Schroeder A, Pan V, Helbig KL, Friedman B, Shinawi M

Journal of medical genetics.. 2015 November 52 (11):754-61. Epub 08/11/2015.